obesity-995x60.png
FEATURED ARTICLES
5 Sponsor Contracting Issues That Delay Clinical Trials — And How To Avoid Them
CTA negotiations don’t have to stall study start-up. Learn five sponsor-side contracting issues that cause delays and practical ways to prevent them.
-
![GettyImages-681726866 patient, payment, reimbursement]( "Where Clinical Trial Reimbursement Gets Complicated")
Where Clinical Trial Reimbursement Gets ComplicatedLearn where participant reimbursement can break down in clinical trials and how clearer payment processes can reduce delays and unnecessary work for research sites.
-
![arena of spectators-GettyImages-1500529551]( "What Ecological Momentary Assessment Taught Us About Real-World Hearing Outcomes")
What Ecological Momentary Assessment Taught Us About Real-World Hearing OutcomesEcological momentary assessment (EMA) reveals how people experience hearing challenges beyond the clinic. Here, researchers highlight its relevance in designing real-world hearing studies.
-
![clinical-trial-study-design-GettyImages-2215843204]( "Harness An Adept IRB's Expertise To Streamline Study Design")
Harness An Adept IRB's Expertise To Streamline Study DesignAn Institutional Review Board protects human research participants by evaluating study ethics, consent, and risks, while providing sponsors with ongoing guidance on complex trial protocols.
SERVICES AND PRODUCTS
Explore the breadth of Altasciences’ expertise in clinical pharmacology studies, supporting regulatory submissions across a diverse range of therapeutic areas.
Managing clinical trial disclosure can be challenging with the ever-evolving regulatory landscape, and varying requirements across different jurisdictions and regulatory bodies. New and updated regulations need to be continuously monitored and assessed for potential impact on an organization, processes and overall strategy.
Ypsomed accelerates clinical progress by reducing barriers across clinical development, enabling earlier study readiness, greater visibility and more informed decisions.
Explore validated pain models and integrated early-phase services designed to characterize dose response, evaluate safety and efficacy, and support informed decisions in analgesic development.
DECODE, the Digital Endpoint Collaboration for Outcomes Development, is Ametris’ pre-competitive collaboration framework designed to help address shared clinical measurement challenges across the life sciences industry. In regulatory contexts where evidence expectations are high, digital measures must be meaningful to patients, scientifically valid, operationally feasible, and aligned with regulatory expectations. By supporting the development and validation of fit-for-purpose, patient-centered digital measures, DECODE helps transform real-world data into validated clinical evidence across clinical research programs.